Mercator Medical Logo

Mercator Medical

ISIN: PLMRCTR00015 | Ticker: MRC | LEI: 259400YONW18M3H4WX66
Sector: Health CareSub-Industry: Health Care Equipment
Country: Poland

About Mercator Medical

Company Description

The Mercator Medical Group is a company from Kraków with Polish capital that officially opened its business in the medical devices market in 1996.

It is one of the two companies in Europe and also one of the few companies in the world that distribute both disposable medical supplies and disposable gloves.

The Group is now one of the most important players on the international scene.

It sells its products to approximately 70 countries in the world and distributes them in Europe.

For over 25 years of its operations, the company has successively established the MERCATOR brand, which is both highly recognisable and well-trusted in the medical industry.

Our portfolio includes a wide range of medical and protective gloves and nonwoven products as well as products from reputable international companies that are distributed exclusively by us.

Year founded

1989

Served area

Worldwide

Headquarters

H.Modrzejewskiej 30, 31-327 Kraków – Poland

Financial statements

Download as Excel
Line item in (pln) 02.01.2020 01.01.2021 02.01.2021 01.01.2022 01.01.2023
Assets N/A 1,289,312,000.00 N/A 1,288,523,000.00 N/A
Noncurrent Assets N/A 193,793,000.00 N/A 374,352,000.00 N/A
Property Plant And Equipment N/A 183,413,000.00 N/A 336,229,000.00 N/A
Intangible Assets Other Than Goodwill N/A 3,871,000.00 N/A 9,649,000.00 N/A
Investments In Subsidiaries Joint Ventures And Associates N/A 0.00 N/A 0.00 N/A
Other Noncurrent Receivables N/A 22,000.00 N/A 99,000.00 60,000.00
Deferred Tax Assets N/A 6,487,000.00 N/A 28,375,000.00 N/A
Current Assets N/A 1,095,519,000.00 N/A 914,171,000.00 N/A
Inventories N/A 207,000,000.00 N/A 230,395,000.00 N/A
Trade And Other Current Receivables N/A 339,513,000.00 N/A 143,637,000.00 N/A
Current Tax Assets Current N/A 49,000.00 N/A 4,838,000.00 N/A
Other Current Financial Assets N/A 149,117,000.00 N/A 195,695,000.00 N/A
Cash and cash equivalents 14,783,000.00 399,840,000.00 399,840,000.00 339,606,000.00 223,344,000.00
Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners N/A 1,095,519,000.00 N/A 914,171,000.00 N/A
Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners N/A 0.00 N/A 0.00 N/A
Current Restricted Cash And Cash Equivalents N/A 263,000.00 N/A 283,000.00 87,061,000.00
Equity And Liabilities N/A 1,289,312,000.00 N/A 1,288,523,000.00 N/A
Equity 134,460,000.00 1,043,140,000.00 N/A 1,145,207,000.00 N/A
Issued Capital N/A 10,604,000.00 N/A 10,647,000.00 N/A
Retained Earnings N/A 963,763,000.00 N/A 1,078,634,000.00 N/A
Share Premium N/A 57,139,000.00 N/A 57,843,000.00 N/A
Other Reserves N/A 123,000.00 N/A 142,000.00 N/A
Reserve Of Sharebased Payments N/A N/A N/A 142,000.00 142,000.00
Equity Attributable To Owners Of Parent N/A 1,039,960,000.00 N/A 1,143,849,000.00 N/A
Noncontrolling Interests N/A 3,180,000.00 N/A 1,358,000.00 N/A
Liabilities N/A 246,172,000.00 N/A 143,316,000.00 N/A
Noncurrent Liabilities N/A 6,282,000.00 N/A 10,262,000.00 N/A
Noncurrent Provisions N/A 1,099,000.00 N/A 2,163,000.00 N/A
Deferred Tax Liabilities N/A 2,957,000.00 N/A 4,348,000.00 N/A
Other Noncurrent Nonfinancial Liabilities N/A 202,000.00 N/A 227,000.00 N/A
Longterm Borrowings N/A 0.00 N/A 0.00 0.00
Current Liabilities N/A 239,890,000.00 N/A 133,054,000.00 N/A
Current Provisions N/A 1,902,000.00 N/A 2,328,000.00 N/A
Trade And Other Current Payables N/A 146,348,000.00 N/A 104,807,000.00 N/A
Current Tax Liabilities Current N/A 89,415,000.00 N/A 24,613,000.00 N/A
Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale N/A 239,890,000.00 N/A 133,054,000.00 N/A
Liabilities Included In Disposal Groups Classified As Held For Sale N/A 0.00 N/A 0.00 N/A
Current Borrowings And Current Portion Of Noncurrent Borrowings N/A 686,000.00 N/A 0.00 211,000.00
Line item in (pln) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 1,834,174,000.00 1,727,349,000.00 N/A
Other Income 4,494,000.00 5,739,000.00 N/A
Changes In Inventories Of Finished Goods And Work In Progress -2,269,000.00 -115,436,000.00 N/A
Raw Materials And Consumables Used 252,014,000.00 343,651,000.00 N/A
Cost Of Merchandise Sold 394,526,000.00 815,332,000.00 235,240,000.00
Services Expense 38,479,000.00 61,628,000.00 61,937,000.00
Employee Benefits Expense 78,438,000.00 86,104,000.00 N/A
Depreciation And Amortisation Expense 18,518,000.00 19,306,000.00 N/A
Tax Expense Other Than Income Tax Expense 1,327,000.00 1,234,000.00 1,386,000.00
Other Expense By Nature 3,815,000.00 3,956,000.00 N/A
Profit Loss From Operating Activities 1,047,621,000.00 463,433,000.00 N/A
Finance Income 929,000.00 22,388,000.00 N/A
Finance Costs 7,984,000.00 8,596,000.00 N/A
Profit Loss Before Tax 1,040,566,000.00 477,225,000.00 N/A
Income Tax Expense Continuing Operations 104,997,000.00 32,373,000.00 N/A
Profit Loss From Continuing Operations 935,569,000.00 444,852,000.00 N/A
Profit Loss From Discontinued Operations 0.00 0.00 N/A
Profit (loss) 935,569,000.00 444,852,000.00 -190,786,000.00
Profit Loss Attributable To Owners Of Parent 930,185,000.00 446,865,000.00 N/A
Profit Loss Attributable To Noncontrolling Interests 5,384,000.00 -2,013,000.00 N/A
Line item in (pln) 01.01.2021 02.01.2020 01.01.2022 02.01.2021 01.01.2023
Profit (loss) 935,569,000.00 N/A 444,852,000.00 N/A -190,786,000.00
Adjustments For Reconcile Profit Loss -205,651,000.00 N/A 178,134,000.00 N/A N/A
Adjustments For Decrease Increase In Inventories -117,585,000.00 N/A -23,395,000.00 N/A N/A
Adjustments For Depreciation And Amortisation Expense 18,518,000.00 N/A 19,306,000.00 N/A N/A
Adjustments For Provisions 3,360,000.00 N/A 2,881,000.00 N/A N/A
Adjustments For Unrealised Foreign Exchange Losses Gains 49,000.00 N/A 1,077,000.00 N/A N/A
Adjustments For Losses Gains On Disposal Of Noncurrent Assets -205,000.00 N/A 5,939,000.00 N/A N/A
Other Adjustments To Reconcile Profit Loss -8,227,000.00 N/A -6,958,000.00 N/A N/A
Adjustments For Reconcile Profit Loss -205,651,000.00 N/A 178,134,000.00 N/A N/A
Cash Flows From Used In Operations 729,918,000.00 N/A 622,986,000.00 N/A N/A
Income Taxes Paid Refund Classified As Operating Activities 17,449,000.00 N/A 119,986,000.00 N/A N/A
Cash Flows From Used In Operating Activities 712,469,000.00 N/A 503,000,000.00 N/A N/A
Interest Received Classified As Investing Activities 224,000.00 N/A 388,000.00 N/A N/A
Cash Flows From Used In Investing Activities -161,270,000.00 N/A -230,045,000.00 N/A N/A
Proceeds From Issuing Shares 270,000.00 N/A 747,000.00 N/A N/A
Payments To Acquire Or Redeem Entitys Shares 10,639,000.00 N/A 332,082,000.00 N/A N/A
Proceeds From Borrowings Classified As Financing Activities 0.00 N/A 0.00 N/A N/A
Repayments Of Borrowings Classified As Financing Activities 141,883,000.00 N/A 717,000.00 N/A N/A
Payments Of Lease Liabilities Classified As Financing Activities 1,417,000.00 N/A 1,742,000.00 N/A N/A
Dividends Paid Classified As Financing Activities 8,193,000.00 N/A 0.00 N/A N/A
Interest Paid Classified As Financing Activities 4,231,000.00 N/A 117,000.00 N/A N/A
Cash Flows From Used In Financing Activities -166,093,000.00 N/A -333,911,000.00 N/A N/A
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes 385,106,000.00 N/A -60,956,000.00 N/A -107,332,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents -49,000.00 N/A 722,000.00 N/A N/A
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes 385,057,000.00 N/A -60,234,000.00 N/A -116,262,000.00
Cash and cash equivalents 399,840,000.00 14,783,000.00 339,606,000.00 399,840,000.00 223,344,000.00

Please note that some sums might not add up.

Filings & Publications

2023

Report
Q1
H1
Q3
FY
Consolidated Report
POL
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2022

Report
Q1
H1
Q3
FY
Consolidated Report
POL
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
POL
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2020

Report
Q1
H1
Q3
FY
Consolidated Report
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

PLMRCTR00015

LEI

259400YONW18M3H4WX66

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Equipment

Listed Stock Exchange

Warsaw Stock Exchange

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.